Whitaker Sues FDA Over CoQ10/Statin Issue

Whitaker Sues FDA Over CoQ10/Statin Issue

WASHINGTONOn March 4, JulianM. Whitaker, M.D., filed suit in U.S. District Court for the District ofColumbia against the Food and Drug Administration (FDA) for refusing to changethe warning labels on statin drugs to warn medical professionals and consumersabout the drugs adverse impact on body levels of coenzyme Q10 (CoQ10).Thesuit, filed by Emord & Associates, seeks a court order compelling FDA torequire labeling notices about statins depleting effects on CoQ10 levels andsuggesting CoQ10 supplementation to offset the impact. In addition, Whitaker isseeking declaratory and injunctive relief.